Article
Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Cancer chemotherapy and pharmacology - 1 Oct 2009
Huang Zhao-Hui, Hua Dong, Du Xiang
Abstract excerpt
PURPOSE: The aim of this study was to assess whether genetic polymorphisms in p53, glutathione S-transferase P1 (GSTP1), GSTM1, excision repair cross complementing group 1 (ERCC1) and X-ray repair cross-complementing group 1 (XRCC1) genes are associated with clinical outcome of gastric cancer pat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
